Cell Signaling Technology

Product Pathways - Nuclear Receptor Signaling

Progesterone Receptor A/B Antibody #3176

No. Size Price
3176S 100 µl ( 10 western blots ) ¥3,100.00 现货查询 购买询价
3176 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human, Endogenous 90 (PR-A), 118 (PR-B) Rabbit

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting,

Specificity / Sensitivity

Progesterone Receptor A/B Antibody detects endogenous levels of total progesterone receptor A and B proteins. This antibody does not cross-react with other PR family members.Progesterone Receptor A/B Antibody能够检测内源性水平的总孕酮受体A和B蛋白。该抗体不与其他孕酮受体家族成员发生交叉反应。

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Tyr541 of human progesterone receptor.该多克隆抗体通过用合成肽免疫动物制备,该合成肽是人孕酮受体酪氨酸(541位)附近的残基。

Western Blotting

Western Blotting

Western blot analysis of T47D cell lysate using Progesterone Receptor A/B Antibody.Western blot方法检测T47D细胞裂解物,使用的抗体为Progesterone Receptor A/B Antibody.


Human progesterone receptor (PR) is expressed as two forms: the full length PR B and the short form PR A. PR A lacks the first 164 amino acid residues of PR B (1,2). Both PR A and PR B are ligand activated but differ in their relative ability to activate target gene transcription (3,4). The activity of PR is regulated by phosphorylation; at least seven serine residues are phosphorylated in its amino-terminal domain. Three sites (Ser81, Ser102 and Ser162) are unique to full length PR B while other sites (Ser190, Ser294, Ser345 and Ser400) are shared by both isoforms (5). Phosphorylation of PR B at Ser190 (equivalent to Ser26 of PR A) is catalyzed by CDK2 (6). Mutation of Ser190 results in decreased activity of PR (7), suggesting that the phosphorylation of Ser190 may be critical to its biological function.人孕酮受体(PR)表现为两种形式:全长的孕酮受体B和短的孕酮受体A。PR A缺少PR B的第164个氨基酸残基(1,2)。PR A和PR B都是配体激活,但其激活靶基因转录的相对能力是不同的(3,4)。PR的活性受磷酸化调节。在其氨基末端区域,至少有七个丝氨酸残基被磷酸化。丝氨酸三个位点(81,102,162位)是全长PR特有的,而其他丝氨酸位点(190,294,345和400位)是两个亚型所共有的(5)。PR B丝氨酸(190位)(相当于PR A丝氨酸(26位))的磷酸化是由CDK2催化的(6)。丝氨酸(190位)的突变导致PR活性降低(7),这表明丝氨酸(190位)的磷酸化对其生物功能来说是至关重要的。

  1. Evans, R.M. (1988) Science 240, 889-895.
  2. Kastner, P. et al. (1990) EMBO J. 112, 1603-1614.
  3. Giangrande, P.H. et al. (2000) Mol. Cell. Biol. 20, 3102-3115.
  4. Wen, D.X. et al. (1994) Mol. Cell. Biol. 14, 8356-8364.
  5. Clemm, D.L. et al. (2000) Mol. Endocrinol. 14, 52-65.
  6. Zhang, Y. et al. (1997) Mol. Endocrinol. 11, 823-832.
  7. Takimoto, G.S. et al. (1996) J. Biol. Chem. 271, 13308-13316.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :